Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
11/2006
11/15/2006EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/08/2006EP1303514B9 Process for preparing azacycloalkanoylaminothiazoles
11/07/2006US7132560 Reacting N-methacryloyl-4-cyano-3-trifluoromethylaniline with mono-perphthalic acid to form 4-cyano-N-(2,3-epoxy-2-methylpropionyl)-3-trifluoromethylaniline
11/07/2006US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/02/2006EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/01/2006CN1854138A 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
11/01/2006CN1854118A Indane acetic acid compound
10/2006
10/31/2006US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006US7128730 Apparatus for delivery of therapeutic and/or diagnostic agents
10/26/2006US20060241150 P38 kinase inhibitor compositions and methods of using the same
10/25/2006EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders.
10/24/2006US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/24/2006US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006CA2398963C New salt form and polymorphs
10/18/2006EP1283828B1 Novel polymorph v of torasemide
10/18/2006CN1847253A Process for preparing amine platinum complexes
10/17/2006CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/12/2006US20060229560 Apparatus for delivery of therapeutic and/or diagnostic agents
10/12/2006US20060229559 Apparatus for delivery of therapeutic and/or diagnostic agents
10/12/2006US20060229321 Rosuvastatin in pre demented states
10/10/2006US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006CA2352554C Substituted benzimidazoles and their use as parp inhibitors
10/10/2006CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/04/2006EP1458376B1 Darifenacin for use in the treatment of urgency induced by overactive bladder
10/04/2006EP1425008B1 Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics
10/04/2006CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes
10/04/2006CN1839873A Pharmaceutically active uridine esters
09/2006
09/28/2006US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor
09/20/2006EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/19/2006US7108871 Isoflavones and saponins in defined ratios, menopause, cancer
09/13/2006EP1700603A2 Immunostimulatory nucleic acids
09/13/2006EP1406869B1 Taxol enhancer compounds
09/12/2006US7105530 Pyrimidineamines as angiogenesis modulators
09/12/2006US7105493 Methods and compositions for treating flaviviruses and pestiviruses
09/06/2006EP1698338A2 S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
09/06/2006CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
09/05/2006US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus
08/2006
08/31/2006US20060194804 Hiv replication inhibiting pyrimidines and triazines
08/30/2006EP1551432B1 Argyrolobium roseum plant extracts for treating diabetes
08/30/2006CN1826343A Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/30/2006CN1826333A Diamine derivatives
08/30/2006CN1826121A Method for modulating calcium ion-release-activated calcium ion channels
08/30/2006CN1826120A Compounds for inflammation and immune-related uses
08/30/2006CN1824656A Methods and compositions utilizing quinazolinones
08/30/2006CN1272319C Process for making amlodipine maleate
08/30/2006CN1272031C Use of piper betle leaf extractive for preparing medicament against leishmania
08/23/2006EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug
08/23/2006EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/16/2006CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/15/2006US7091195 Derived from plants; for preventing or inhibiting tumor growth
08/09/2006EP1688418A2 Chemokine receptor antagonists and methods of use thereof
08/09/2006EP1252889B1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
08/08/2006US7087603 Pyrazole compounds useful as protein kinase inhibitors
08/02/2006EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
08/02/2006EP1686113A1 Inhibitors of aspartyl protease
08/02/2006EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine
08/02/2006EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine
08/02/2006CN1810802A 3-substituted-4-pyrimidone derivatives
08/01/2006US7084168 Indoline derivatives
07/2006
07/27/2006US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
07/27/2006US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias
07/27/2006US20060166865 A modified nucleoside comprising a purine ring for treating viral infections
07/27/2006US20060165792 Controlled release oxycodone compositions
07/27/2006US20060165791 Oral dosage form prepared by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules; improving efficiency and quality of pain management
07/25/2006US7081461 Quinazoline compounds and pharmaceutical compositions containing them
07/20/2006WO2006075949A1 Component for forming a seal around an opening in the skin
07/20/2006US20060160882 Indoline derivatives
07/20/2006US20060160733 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
07/20/2006CA2592774A1 Component for forming a seal around an opening in the skin
07/19/2006CN1805963A Cannabinoid receptor ligands and uses thereof
07/12/2006CN1800175A Amino alcohol derivatives
07/12/2006CN1263758C 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias
07/12/2006CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof
07/05/2006EP1676845A1 New quinazoline derivatives
07/05/2006EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/05/2006CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren
07/04/2006CA2364719C 2-aminopyridines containing fused ring substituents
06/2006
06/29/2006US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines
06/28/2006EP1674102A1 Use of flibanserin in the treatment of sexual disorders
06/27/2006US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus
06/27/2006US7067493 Single dose azithromycin
06/21/2006EP1671949A2 Substituted phenylamines and pyridinylamines
06/21/2006EP1244647B1 Quinazoline derivatives as vegf inhibitors
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1259912C Citalopram for the treatment of elevated blood pressure
06/14/2006EP1669073A2 Fulvestrant formulation
06/13/2006CA2433288C Process for making amlodipine maleate
06/08/2006US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer
06/07/2006EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
06/07/2006EP1666092A2 Drug combination comprising a fatty acid and a uridine compound.
06/07/2006EP1666034A1 Pharmaceutical combination comprising a biguanide
06/07/2006CN1784406A Purification and crystalline forms of zaleplon
06/07/2006CN1781927A Mevalonic acid derivative
06/07/2006CN1781911A Intermediate for producing novel pyrazine derivatives
06/06/2006US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8)
06/01/2006US20060116374 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
06/01/2006DE19849107B4 Verfahren zur Entfernung von unerwünschten, endogen vorhandenen toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A method for removing unwanted endogenously present toxic alkaloids from plants or herbal preparations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 32